Merck shares rose 1.27% in premarket trading.

Tiger Newspress2021-12-22

Merck shares rose 1.27% in premarket trading.

Merck and Ridgeback Biotherapeutics announce that the U.K. Government will purchase an additional 1.75M patient courses of molnupiravir (MK-4482), an investigational oral antiviral COVID-19 medicine.

In the U.K., Lagevrio is the planned trademark for molnupiravir.

This additional procurement agreement follows a previous deal for 480K courses of treatment by U.K., totalling up to 2.23M courses of molnupiravir.

In early November,U.K.'s regulatory agency authorized Merck's COVID-19 pill.

Also, Merck  has entered into a procurement agreement with the U.S. to supply ~3.1M courses of molnupiravi rand to deliver 1.6M courses to Japan.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • SSVC
    2021-12-23
    SSVC
    Good Appreciate your response and comments Thanks 
    • SSVC
      [Strong][ShakeHands]
    • Alfred1007
      looks stable..one of the top biopharma companies in the world.
  • TK360
    2021-12-22
    TK360
    Nice 
  • ppp00
    2021-12-22
    ppp00
    Please help to like 
    • JeremyKok
      hi. please help like and comment back. thank you.
  • Kiranaar
    2021-12-22
    Kiranaar
    Probably a short lived excitement
  • Grit100
    2021-12-22
    Grit100
    Ok
发表看法
5